Corneal graft rejection: Recent updates

International Ophthalmology Clinics

Volumn 42, Issue 1, 2002, Pages 105-113

  Tham, Vivien M B ^a   Abbott, Richard L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISOLONE ACETATE;

CLINICAL FEATURE; CONFERENCE PAPER; CORNEA TRANSPLANTATION; CORTICOSTEROID THERAPY; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MEDICAL EDUCATION; PATIENT EDUCATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK FACTOR;

EID: 0036141709     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004397-200201000-00015     Document Type: Conference Paper

References (25)

1. Different influences on corneal graft survival in 539 transplants
2. The Australian corneal graft registry, 1990-1992 report
3. Report of the organ transplant panel corneal transplantation
4. Ten-year postoperative results of penetrating keratoplasty
5. Risk factors of corneal graft failure
6. Risk factors for graft failure in penetrating keratoplasty
7. The collaborative corneal transplantation studies
8. Corneal graft outcome study
9. Hierarchy of prognostic factors for corneal allograft survival
10. Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative corneal transplantation studies
11. Effect of factors unrelated to tissue matching on corneal transplant endothelial rejection
12. Risk of endothelial rejection after bilateral penetrating keratoplasty
13. The effect of ocular inflammation on corneal grafts
14. Factors predictive of corneal graft survival
15. The role of glaucoma therapy in the need for repeat penetrating keratoplasty
16. Patient-reported symptoms associated with graft reactions in high-risk patients in the collaborative corneal transplantation studies
17. Clinical types of corneal transplant rejection. Their manifestations, frequency, preoperative correlates, and treatment
18. Corneal transplant allograft rejection: Possible predisposing factors
19. Current practices in the prevention and treatment of corneal graft rejection
20. Corticosteroids in corneal graft rejection. Oral versus single pulse therapy
21. Corticosteroids in corneal graft rejection. Double versus single pulse therapy
22. The use of cyclosporine in high-risk keratoplasty
23. Systemic cyclosporine in high-risk keratoplasty. Short versus long-term therapy
24. Update on topical cyclosporine A: Background, immunology and pharmacology